Puma Biotechnology, Inc. (PBYI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 15.42M | 14.42M | 9.69M | 14.08M | 3.61M | 15.61M | 11.04M | 1.03M | 11.25M | 10.46M | 10.62M | 3.3M |
| Operating CF Margin % | 34.4% | 19.11% | 17.79% | 26.86% | 7.85% | 26.42% | 13.7% | 2.18% | 25.7% | 14.49% | 18.92% | 6.04% |
| Operating CF Growth % | 326.8% | -7.61% | -12.22% | 1271.18% | -67.88% | 49.28% | 3.98% | -68.84% | 325.5% | 36.08% | -38.5% | 123.76% |
| Net Income | -3.75M | 13.44M | 8.84M | 5.86M | 2.97M | 19.3M | 20.32M | -4.53M | -4.82M | 12.27M | 5.8M | 2.13M |
| Depreciation & Amortization | 2.58M | 2.66M | 2.72M | 2.76M | 2.8M | 2.84M | 2.88M | 2.91M | 2.9M | 2.89M | 2.88M | 2.88M |
| Stock-Based Compensation | 1.9M | 1.62M | 1.67M | 1.63M | 2.03M | 1.75M | 2.05M | 2.06M | 2.38M | 2.43M | 2.54M | 2.43M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -7.08M | 0 | 0 | 0 | 0 | 2.42M | 2.18M |
| Other Non-Cash Items | 6K | 3.25M | -209K | -362K | 213K | -398K | -48K | -183K | 110K | 367K | -1.79M | -1.66M |
| Working Capital Changes | 14.68M | -6.54M | -3.34M | 4.2M | -4.4M | -818K | -14.16M | 769K | 10.68M | -7.5M | -1.23M | -4.65M |
| Change in Receivables | 27.32M | -20.09M | -7.44M | -376K | 6.63M | 23.03M | -26.49M | -3.34M | 23.14M | -19.23M | 2.32M | -640K |
| Change in Inventory | -3.18M | 3.96M | -885K | 160K | -27K | -6.05M | 6.38M | -1.95M | -20K | -1.4M | 1.95M | -3.74M |
| Change in Payables | 3.11M | -1.33M | 962K | -602K | 517K | -2M | -5.99M | 4.54M | 2.08M | 1.83M | -2.73M | -794K |
| Cash from Investing | 2.47M | -26.98M | 506K | -11.25M | 1.53M | -2.32M | 259K | 703K | -19.08M | -8.17M | 11.18M | -4.68M |
| Capital Expenditures | 0 | 36K | -26K | -20K | -61K | -16K | -20K | -20K | 0 | -45K | -27K | -68K |
| CapEx % of Revenue | - | 0.05% | 0.05% | 0.04% | 0.13% | 0.03% | 0.02% | 0.04% | - | 0.06% | 0.05% | 0.12% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.21M | 68K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.21M | -68K |
| Cash from Financing | -11.3M | -11.33M | -11.33M | -11.2M | -11.33M | -11.33M | -11.18M | -11.33M | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | -11.11M | -11.11M | -11.11M | -11.11M | -11.11M | -11.11M | -11.11M | -11.11M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 130K | 0 | 0 | 150K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -190K | -222K | -222K | -222K | -222K | -221K | -223K | -222K | 0 | 0 | 0 | 0 |
| Net Change in Cash | 6.56M | -23.89M | -1.14M | -8.37M | -6.19M | 1.96M | 114K | -9.6M | -7.83M | 2.29M | 21.79M | -1.39M |
| Free Cash Flow | 15.42M | 14.46M | 9.66M | 14.06M | 3.55M | 15.59M | 11.02M | 1.01M | 11.25M | 10.41M | 10.59M | 3.23M |
| FCF Margin % | 34.4% | 19.16% | 17.74% | 26.82% | 7.72% | 26.39% | 13.68% | 2.14% | 25.7% | 14.42% | 18.87% | 5.92% |
| FCF Growth % | 334.13% | -7.29% | -12.3% | 1296.42% | -68.42% | 49.77% | 4.06% | -68.8% | 214.09% | 1424.16% | -38.65% | 123.27% |
| FCF per Share | 0.30 | 0.28 | 0.19 | 0.28 | 0.07 | 0.32 | 0.22 | 0.02 | 0.23 | 0.22 | 0.22 | 0.07 |
| FCF Conversion (FCF/Net Income) | -4.11x | 1.07x | 1.10x | 2.41x | 1.21x | 0.81x | 0.54x | -0.23x | -2.34x | 0.85x | 1.83x | 1.55x |
| Interest Paid | 0 | 980K | 0 | 1.61M | 1.92M | 2.29M | 2.67M | 2.91M | 2.91M | 2.91M | 2.91M | 2.91M |
| Taxes Paid | 0 | 247K | 0 | 929K | 101K | -1.17M | 248K | 800K | 122K | 246K | 253K | 96K |